Sun, Aug 18 1:53pm

Big Percentage Gainers (1)

Myriad Genetics Inc [MYGN]
$25.35 2.15 (9.27%)

MYGN Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.69 Billion
MYGN Description

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies.

Visit Website

MYGN Earnings

EPS -0.06 P/E Ratio 106.83
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 13, 2019 (5 days ago) -44.02%

MYGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

MYGN Charts

1 Year
Jun 25, 2019
Sep 4, 2018

Symbol Price Day % YTD %
MYGN $25.35 9.27% -12.59%

Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy